Mikhail Blagosklonny is an oncologist who has been trying to alert the cancer treatment community on the effectiveness of a certain drug. That drug is named Rapamycin, and while it is regularly used to stave off organ transplant rejections, it has some interesting properties that make it a good candidate against cancer. The drug was discovered on Easter Island, and was orgiginally used as an anti-fungal drug. After it was found that it also contained antiproliferative and immunosuppresive abilities, it started to be used for much more.
Mikhail Blagosklonny, has been studying and doing research for therapies that can help with the fight against cancer for some time now. As the Editor-in-Chief for Oncotarget, he has also focused, heavily, on anti-aging and how cancer relates to the aging process. He has put forward the proposition that not only can Rapamacyin aid in the battle with cancer, but that it may also be able to extend the life of humans. Without his contributions that add greatly to the knowledge base of Rapamycin’s capabilities, we would not know the wide variety of potential therapies that the drug can be used for. Read more about Mikhail on Crunchbase.
Rapamycin, as Mikhail Blagosklonny knows, is a much better option than other drugs that work to prevent kidney transplant failures. These other drugs, which are called immonosuppressive drugs or calcineurin inhibitors can come with a list of side effects that harm the kidneys over time. Since Rapamycin has been shown to not be nearly as toxic to the kidneys as these drugs are, it has been used for the purpose of making kidney transplants a much smoother procedure. Rapamycin also treats patients with hemolytic-uremic syndrome, Lymphangioleiomyomatosis (LAM), helps to coat coronary stents to prevent re-stenosis in the arteries, cancer, and Tuberous Sclerosis Complex (TSC).
As a professor, researcher, philanthropist, and proponent for Rapamycin, Mikhail Blagosklonny hopes to make the world a better place by making cancer treatment and other kinds of treatments more affordable for the regular person. His main interest in his research is cancer and aging, and he works hard to discover a connection between the aging population and cancer. While his research has been amazing, a lot of the impact he has made in the world has come from the fact that he is an excellent professor. His students have always been inspired by his passion, and he hopes that one or more of them will take up his fight when he is long gone.
A large part of what differs from Mikhail Blagosklonny and other cancer researchers is the fact that he wants to make treatment something that is not a luxury only for the few who can afford it. He also doesn’t want people to have to suffer as much as they do now while they endure cancer treatment that causes pain. It is his greatest desire to discover a cancer treatment that will not effect the healthy cells in the human body but that will only destroy the cancerous ones. The world is better off due to the efforts of people like Mikhail Blagosklonny. Know more about Mikhail at Onmogul.com.